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ABSTRACT
The annealing of nucleic acids to (partly) comple-
mentary RNA or DNA strands is involved in import-
ant cellular processes. A variety of proteins have
been shown to accelerate RNA/RNA annealing but
their mode of action is still mainly uncertain. In order
to study the mechanism of protein-facilitated accel-
eration of annealing we selected a short peptide,
HIV-1 Tat(44–61), which accelerates the reaction
efficiently. The activity of the peptide is strongly
regulated by mono- and divalent cations which
hints at the importance of electrostatic interactions
between RNA and peptide. Mutagenesis of the
peptide illustrated the dominant role of positively
charged amino acids in RNA annealing—both the
overall charge of the molecule and a precise distri-
bution of basic amino acids within the peptide are
important. Additionally, we found that Tat(44–61)
drives the RNA annealing reaction via entropic
rather than enthalpic terms. One-dimensional-NMR
data suggest that the peptide changes the popula-
tion distribution of possible RNA structures to favor
an annealing-prone RNA conformation, thereby
increasing the fraction of colliding RNA molecules
that successfully anneal.
INTRODUCTION
As with proteins, the folding of RNA molecules into their
native and functional structure is a non-trivial problem
(1,2). These folding problems are not only in vitro artefacts
but do also exist in vivo (3,4). It is assumed that certain
proteins assist refolding events in vivo in a non-speciﬁc and
ATP-independent manner and thereby support RNA mol-
ecules in the process of obtaining their native structure.
These proteins have been deﬁned as ‘RNA chaperones’;
proteins ‘that resolve misfolded structures’ (1,5). Although
most proteins that were shown experimentally to assist
nucleic acid folding in a non-speciﬁc way were named
nucleic acid chaperones (1,6), we recently demonstrated
the necessity of discriminating between the mere acceler-
ation of annealing and actual unfolding of RNA struc-
tures (7). As proteins can have either only one or both
of these two activities, we suggested the following nomen-
clature: (i) ‘nucleic acid annealers’ are proteins that, with
no sequence-speciﬁcity, accelerate annealing of comple-
mentary nucleic acids but are not able to dissolve RNA
structures. (ii) ‘RNA chaperones’ destabilize RNA
double-stranded nucleic acid regions (and might in
addition accelerate annealing). The necessity of this dis-
crimination is supported by the ﬁnding that some
DEAD-box RNA helicases exert strand displacement
activity in the presence of ATP but are not able to
dissolve RNA structures in the absence of ATP, while
still retaining their ability to accelerate annealing. For
the human RNA helicase II/Gu protein even the
physical separation of RNA unwinding and annealing
activities was shown (8,9). RNA annealers and chaperones
are extremely diverse and do not share a common amino
acid motif (5). It is thus not clear which sequence or struc-
tural features determine whether a protein exhibits only
one or both of the mentioned activities.
Proteins with nucleic acid annealing activity have been
found in viruses (10–12), bacteria (13–15) and eukaryotes
(6,16–28). The biological role of proteins with annealing
activity ranges from bacterial translational regulation to
the maturation of eukaryotic transcripts and RNA editing
in kinetoplastid organisms. Due to the complexity and
difﬁculty of in situ annealing assays, the potential role of
nucleic acid annealers has so far only been assayed in
in vitro experiments. Thus, the question whether they
also exert the characterized activity on the described sub-
strates in vivo remains unanswered.
All groups that studied protein-accelerated annealing in
greater detail concordantly found basic amino acids to be
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to, the annealing activity (18,20,26,27). The proposed
mechanisms for annealing acceleration are: (i) active
increase of local RNA concentration, (ii) stabilization of
the annealing transition state by shielding the negative
RNA backbone charges, (iii) ‘conversion’ of the RNA
into an annealing-prone conformation (17,19,29).
However, the following questions remain unanswered:
do amino acids other than positively charged ones play
a role for the annealing activity? Do nucleic acid annealers
share a common mechanism or distinct features? Is there a
more precise deﬁnition of amino acid composition and
arrangement in nucleic acid annealers? Here, we used a
model RNA annealer protein to address these questions.
The HIV-1 transactivator of transcription (Tat) is one
of the early regulators of the viral life cycle. By binding to
the TAR RNA, a structure formed by the nascent viral
transcript, Tat recruits cellular factors to the HIV-1
promoter and indirectly stimulates viral transcription.
(30,31) Tat was also suggested to play a role in other
cellular and viral processes including translation (32),
interaction with the RNAi machinery (33–35), PKR regu-
lation (36,37), viral mRNA capping (38) and reverse tran-
scription (39–41).
More recently, the Tat protein as well as its fragment
Tat(44–61) were found to exhibit nucleic acid chaperone
activity (42). In Tat(44–61), which comprises the basic
domain and part of the core domain of the full-length
protein, the authors claimed to have found the smallest
known RNA chaperone to date. Due to its small size we
selected Tat(44–61) as a model peptide for our studies on
proteins that assist RNA folding.
Although we could not reproduce the protein’s RNA
strand displacement activity, the full-length Tat protein
and its fragment Tat(44–61) are potent nucleic acid an-
nealers. We subjected Tat(44–61) to a detailed mutational
analysis to identify the amino acids that are crucial for the
annealing activity of the peptide. We conﬁrmed the essen-
tial role of basic amino acids, but also found evidence for
the contribution of polar amino acids that can potentially
hydrogen bond with the RNA backbone. We found the
peptide’s overall charge and the arrangement of basic
amino acids within the peptide important for RNA an-
nealing acceleration. Furthermore, we demonstrated that
the acceleration of annealing is conferred by an increase in
transition state entropy. One-dimensional (1D)
1H NMR
data show that the population of possible RNA structures
is changed in the presence of Tat(44–61). Thus, either the
peptide selectively binds a preexisting RNA conformation
and thereby shifts the equilibrium or it changes the struc-
ture of the RNA molecule upon binding. In either case the
abundance of annealing-prone RNA conformations is
increased which raises the fraction of colliding RNA mol-
ecules that efﬁciently anneal with each other.
MATERIALS AND METHODS
RNAs and peptides
All RNAs used were synthesized on solid phase
(Eurogentech). Lyophilized RNAs were dissolved in
DEPC water and stored at  20 or at  80 C (for
long-term storage). The nucleic acid substrates used for
the FRET-based assay in this study are listed in
Supplementary Table S1.
Synthetic peptides were provided by ThermoFischer
Scientiﬁc, peptides scr1-3, K7A R13A and K7A R9A
R13A were a generous gift of Peter Steinlein, Research
Institute for Molecular Pathology Vienna, Austria. The
peptides were dissolved in DEPC water, aliquoted,
freeze-dried and stored at  20 C. Shortly before use
they were dissolved and diluted in 30mM Tris–HCl
pH 7, 30mM NaCl and 1mM DTT. Mass spectrometry
results conﬁrmed the sequence identity and integrity of
Tat(44–61) that had been stored lyophilized at  20 C
for several months. Although modiﬁcations (such as
hydrolysis) of the peptide upon short-time storage in
solution are unlikely, we cannot completely exclude this
possibility. The fact that the peptide can accelerate anneal-
ing of two complementary sequences, however, hints at it
being active. The recombinant full-length Tat protein was
delivered in a freeze-dried form by Jena Bioscience and
dissolved in degassed 100mM Tris–HCl pH 7.5, 150mM
NaCl and 10mM DTT. The full-length Tat protein is very
sensitive to inactivation through oxidation and aggrega-
tion (43) and is thus difﬁcult to handle. We excluded
degradation of the protein on SDS–PAGE and conﬁrmed
the correct protein sequence by mass spectrometry.
Furthermore, we took precautions to avoid oxidation of
the protein such as degassing all solutions.
FRET-based annealing and strand displacement assays
Combined nucleic acid annealing and strand displacement
assays as well as annealing assays were carried out as
described by Rajkowitsch and Schroeder (2007) (44), at
30 C if not indicated otherwise, and using the following
concentrations: 10nM of each RNA strand, 50mM Tris–
HCl in the pH range of 6.5–8, 2mM DTT and salt
concentrations as indicated in the text. Annealing curves
were ﬁtted by non-linear regression to the following
second-order reaction equation using GraphPadPrism
(with Y being the normalized FRET index and the
time X):
Y ¼ amplitude   1  
1




Filter binding assays were conducted according to ref. (45)
with the following changes: the reaction buffer contained
50mM Tris–HCl pH 7, 2mM DTT and 6% glycerol.
Reactions were incubated for 5min at room temperature
before ﬁltering. Binding curves were ﬁtted to a Hill
equation [Equation (2)] using GraphPadPrism.
(Y, relative amount of ﬁlter-bound RNA; Bmax, maximally
bound RNA; h, Hill coefﬁcient; KD, binding constant;
X, peptide concentration)
Y ¼
Bmax   Yh
Kh
D+Xh : ð2Þ
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and Hill coefﬁcients which have also been faced by other
groups (Michael F. Jantsch, personal communication), we
moved on to recording binding curves for the mutant of
interest (or the wild-type peptide under the salt condition
of interest) in parallel with the wild-type mutant under no
salt conditions. We thus obtained relative KD values and
Hill coefﬁcients. Other common techniques to determine
binding constants, like mobility shift assays, quenching
methods and ITC, were not applicable to our system
due to their speciﬁc limitations.
Aggregation assays
Aggregation through proteins was measured on the basis




double-stranded 21R RNA were incubated at 30 C for
3min in aggregation buffer (50mM Tris–HCl pH 7,
2mM DTT, NaCl and MgCl2 concentrations as indicated
in each single experiment) in the presence or absence of
100–300nM Tat(44–61) or  0.1mg/ml BSA (NEB), total
volume 40ml. After a 10min centrifugation at 13.4 ga t
room temperature, 5ml of the supernatant were removed
carefully and subjected to Scintillation analysis.
Gel annealing and strand displacement assays
Due to temperature limitations of the multiplate reader,
the rate constants’ temperature dependence was measured
using gel annealing assays: 10nM Cy5-labeled 21R
+were
pre-incubated with or without 300nM peptide in 50mM
Tris–HCl pH 7, 0.5mM MgCl2 and 2mM DTT ﬁnal con-
centrations at the temperature of interest. The annealing
reaction was started by adding 10nM ﬁnal concentration
of Cy3-labeled 21R
–. Ten microliter-aliquots were taken
after the indicated time points, mixed with 2.5ml5   stop
buffer (3mM 21R
+, 2% SDS, 150mM EDTA, 15%
sucrose, 12.5% ﬁcoll) and directly loaded onto a running
15% native PAGE (1  TBE). Fluorescent signals of both
Cy5 and Cy3 were scanned with a Typhoon
TM 9400 (GE
Healthcare), quantiﬁed with ImageQuant
TM and anneal-
ing curves were ﬁtted to Equation (1) using
GraphPadPrism.
The full-length Tat protein is susceptible to aggregation
(43) which disturbed the ﬂuorescent signal in the
FRET-based assay so that an evaluation of the resulting
curves was not possible. We thus carried out gel strand
displacement assays. Strand displacement gel assays were
conducted in a similar way to the annealing gels, apart
from the following changes: to start the reaction a
10-fold excess of competitor was added to an already
formed double-stranded substrate. The reaction was
stopped using a 2.5  stop buffer containing 60mM
EDTA, 0.5mg/ml yeast tRNA, 0.6% SDS, 30% sucrose
and 12.5% ﬁcoll.
Calculations of kinetic parameters
The reaction constants kobs, determined at different tem-
peratures, were divided by the RNA concentration used in
the gel annealing assay. From these normalized rate con-
stants, k, an Arrhenius plot was derived (17,47). The slope
of the Arrhenius plot yielded the activation energy Ea of
the annealing reaction (R—gas constant):
Ea ¼ slope    R ðÞ : ð3Þ
The free activation energy G
6¼ was derived according to
the Eyring–Polyani relation (48) from the normalized rate
constant k at a speciﬁc temperature T:
G6¼ ¼  RT ln
k   h
kB   T

ð4Þ
(h—Planck’s constant equivalent to 6.626 10
 34 Js, kB—
Boltzmann’s constant equivalent to 1.381 10
 23JK
 1).
Based on Ea and G
6¼, the thermodynamic parameter
enthalpy H
6¼ and entropy S
6¼ were calculated using
Equations (5) and (6).




  G6¼   H6¼ 
: ð6Þ
Interaction between RNA and peptide: NMR spectroscopy
To probe the interaction between RNA and peptide, a
series of titration NMR experiments were recorded.
Spectra were measured at temperatures between 273 and
320K on either a Varian 600MHz spectrometer equipped
with a z-grad HCN probe or a Bruker 700MHz spectrom-
eter equipped with a cryogenic z-grad HCN probe. In all
samples H2O was exchanged with D2O by multiple cycles
of freeze-drying and resolvation in 99.999% D2O (Sigma
Aldrich).
1H pulses were applied at the resonance of the
water frequency with ﬁeld strength of 15.6kHz. One
hundred and twenty-eight transients were averaged, the
relaxation delay was set to 1.5s and the spectral width
was 10ppm. Hard power pulses were applied at the
water frequency, 16kpts were recorded for t1. Spectra
were processed and analyzed using NMRpipe and
NMRdraw (49). For processing, an exponential window
function with a LB factor of 1.5Hz was applied.
Starting from an idealized A-form helical 21R
+ RNA
(the structure was calculated with CNS using a restrained
TAD simulated annealing protocol starting from an
extended structure and applying canonical A-form re-
straints) the chemical shifts were calculated using the
program NUCHEMICS (50,51) and were subsequently
translated into NMR spectra with the NMRSIM
module of TOPSPIN.
1H chemical shifts are referenced
directly to TSP as an external reference. Notably, upon
addition of peptide to the RNA sample a white precipi-
tate appeared which we assumed to be a fraction of the
RNA–peptide complex. Precipitation was probably
caused by high working concentrations (400mM RNA
and 400 or 800mM peptide). Thus, the concentration of
peptide and RNA in solution was somewhat smaller than
intended.
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Tat and its fragment Tat(44–61) have nucleic acid
annealing activity, but no strand displacement activity
The assays conducted and described by Kuciak et al. (42)
implied that the HIV-1 Tat protein possesses two distinct
activities: namely acceleration of annealing and destabil-
ization of nucleic acid structures. Although some of these
assays made use of potential natural substrates of Tat,
both the RNA ribozyme and the RNA trans-splicing
assay suggested that the protein has sequence non-speciﬁc
RNA chaperone activity.
In order to conﬁrm the described activities we used
Tat(44–61) in a two-phase FRET-based assay
(Figure 1A) that has previously been described and
used for several potential RNA chaperone proteins
(14,44). As anticipated, Tat(44–61) considerably
accelerated annealing of the 21R substrate
(Supplementary Table S1), a 21 base-pair long,
blunt-ended, artiﬁcial RNA duplex [Tm=72.4 C,
calculated using the DINAMelt server (52)] (Figure 1B,
phase I). The peptide was however not active in the
second (strand displacement) phase of the assay while
the positive control StpA efﬁciently catalyzed strand
displacement. Remarkably, Tat(44–61) also accelerated
annealing of the DNA substrate 21D while not
catalyzing strand displacement by a competitor DNA
(Supplementary Figure S1). To exclude the possibility of
the 21R double-stranded substrate being too stable for
peptide mediated unfolding we used the jm1 substrate
which has a lower GC content (Tm=49.3 C), with the
same result (Supplementary Table S1 and Figure S2C).
Some proteins are known to need a single-stranded or
helical binding platform to perform double-strand un-
winding (8). To test this possibility for Tat(44–61) we
used a 46nt RNA, which forms a short hairpin at the
30-end, together with a partly complementary 21-mer in
the combined FRET-based assay (jm1heli substrate).
Annealing of this substrate was accelerated by the
peptide, whereas no strand displacement was detected
(Supplementary Figure S2D). Other variations of the
assay included using different temperatures (30 and
37 C), testing several peptide to nucleotide ratios (10nM
to 1mM peptide per 10nM RNA), changing the concen-
trations of MgCl2 and NaCl, using exactly the same buf-
fer composition as described by ref. (42) (buffer A) as well
as testing peptide buffers with different ZnCl2 concen-
trations. While we could always detect an acceleration
of annealing, the peptide did not catalyze strand displace-
ment under any of the applied conditions (Supplementary
Figure S2A, B, E and F).
To test the full-length Tat protein’s ability to promote
strand displacement we conducted polyacrylamide gel
assays using the 21R substrate, with CsdA as a positive
control (Supplementary Figure S3). Again, we could not
detect an RNA chaperone activity.
To ensure that the contradiction in results were
not caused by a limitation in our assay we carried out
the DNA strand displacement assay as described by
Kuciak et al. (42) (Supplementary Figure S4) and the
trans-splicing assay (53) (Supplementary Figure S5).
Despite all positive controls showing activity, we could
not reproduce the reported activities of the full-length
Tat protein and Tat(44–61) in these RNA chaperone
assays.
We therefore conclude that Tat and its fragment are
facilitators of annealing but not RNA chaperones. Due
to its strong annealing activity, the small size, good avail-
ability and easy handling of Tat(44–61) we used it as a
model RNA annealer and studied its annealing activity in
greater detail.
Figure 1. Tat(44–61) accelerates annealing of two complementary
RNAs but does not promote strand displacement. (A) Scheme of the
FRET-based combined annealing and strand displacement (SD) assay
according to Rajkowitsch and Schroeder (44). Two short complemen-
tary RNAs, labeled with a Cy3- (donor) and a Cy5-dye (acceptor),
respectively, are annealed in a microplate (phase I). The close proximity
of the two dyes results in a ﬂuorescence resonance energy transfer
(FRET) when the donor dye is excited. Both ﬂuorescent emission
signals are measured at 1s intervals using a microplate reader, and
the FRET index is calculated as the ratio of the FRET to the
Cy3-signal. Strand displacement is detected in phase II of the assay
which is started through the addition of an unlabeled competitor
RNA and results in a decrease of the FRET signal. (B) The assay
was conducted with 21R RNA in the absence or presence of 1mM
Tat peptide and at 30 C. E. coli StpA (1mM) was used as a positive
control. For clarity, the FRET index was normalized to 1 (phase I and
II) and 0 (only phase I).
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concentration of mono- and divalent cations
Tat(44–61) accelerated annealing with very similar kobs
between pH 6.5 and 7.5 (Supplementary Figure S6). We
thus measured acceleration of annealing at pH 7. We also
tested the inﬂuence of mono- and divalent cations on the
peptide’s activity (Figure 2). Consistent with the kinetic
salt effect, the reaction constant of the ‘RNA only’
reaction increased with rising NaCl or MgCl2 concentra-
tion (47). In comparison to ‘no salt’ conditions 100mM
NaCl and 10mM MgCl2 accelerated annealing 1.5- and
3-fold, respectively (data not shown). Tat(44–61) does not
require any cations for its annealing activity: the peptide
accelerated annealing  7- to 8-fold when no or only low
amounts of ions were present. These kacc values [with
kacc=kobs(peptide)/kobs(RNA only)] are in good agree-
ment with the calculated acceleration of annealing
measured with gel annealing assays (kacc=6 and 9.5 at
10 or 20 C, respectively, as derived from the kobs values in
Figure 6).
Acceleration of annealing by Tat(44–61) was strongly
impaired at MgCl2 concentrations >2mM and NaCl con-
centrations above 60mM (Figure 2). Similar dependences
on MgCl2 concentrations have been reported for HIV-1
NCp7 although the nucleocapsid protein was tolerant for
NaCl concentrations of up to 90mM (10). Both Na
+and
Mg
2+ ions have been shown to compete with positively
charged peptides for the interaction with RNA (54,55).
Thus, the dependence of the peptide’s activity on the ion
concentration hints at the importance of ionic interactions
between the peptide’s basic amino acids and the negatively
charged RNA backbone for the acceleration of annealing
by Tat(44–61).
All basic amino acids are similarly important for the
annealing activity of Tat(44–61)
The importance of basic amino acid stretches in nucleic
acid annealing was reported by several groups
(10,17–20,26,56,57) and is now generally accepted,
although the speciﬁc role of the positive charges during
the annealing process is under debate and might differ for
each protein. The presence of eight basic residues in the 18
amino acid long sequence of Tat(44–61) supports the hy-
pothesis of a mainly charge driven annealing acceleration
process. The small size of the Tat peptide prompted us to
explore the contribution of individual amino acids to its
activity.
A set of peptides with single amino acid substitutions
was therefore tested for their annealing activity in our
FRET-based annealing assay (Figure 3, Supplementary
Figure S7). Figure 3B shows the mutants’ kobs normalized
to the wild-type kobs. Relative kobs values were conﬁrmed
for a few selected mutants using gel annealing assays (data
not shown).
Strikingly, each time a basic amino acid was replaced by
an alanine the peptide’s activity was decreased by a factor
of three. The position of the exchanged residue within the
primary sequence did not seem to be important at all.
Furthermore, the Y4R mutant in which a charge was
added to the peptide was more active than the wild-type
peptide while the Y4Q mutant did not accelerate anneal-
ing any different from Tat(44–61). The double and triple
mutants (K7A R13A and K7A R9A R13A) did not accel-
erate annealing under the tested conditions. Only when we
added mutant peptide amounts in the 10mM range could
we detect an activity similar to the activity of 300nM
wild-type peptide (Supplementary Figure S8).
The mutation of the polar amino acids serine (at
position 3) and glutamine (position 11) that could theor-
etically interact with the RNA via hydrogen bonds or Van
der Waals interactions did not show an effect. However,
the exchange of isoleucine (position 2) for a threonine
increased the peptide’s annealing activity. The additional
threonine might either enhance the activity indirectly, for
example by increasing the peptide’s stability and/or solu-
bility. Alternatively, it might act directly by interacting
with the RNA. Threonine has indeed often been shown
to make contacts with phosphates of the nucleic acid
backbone (58).
Together, these results demonstrate that the presence of
a certain amount of basic residues is indispensable for the
peptide to confer RNA annealing acceleration. Amino
acids with the ability to hydrogen bond might support
the annealing activity. This observation further bolsters
the hypothesis of backbone phosphate charges conferring
peptide/RNA binding. These (mainly ionic) interactions
would explain the promiscuity of the peptide’s annealing
Figure 2. Mono- and divalent cations are detrimental to the peptide’s
annealing activity. FRET-based annealing assays with 21R RNA were
carried out in the absence or presence of 300nM Tat(44–61), and at
different MgCl2 and NaCl concentrations. The reaction constants (kobs)
of the reaction in the presence of peptide were divided by the kobs of
the ‘RNA only’ reaction, yielding kacc. Acceleration of annealing by the
peptide was strongly impaired at MgCl2 concentrations above 2mM
and NaCl concentrations >60mM.
Nucleic Acids Research, 2011,Vol.39, No. 10 4409activity towards different RNA substrates as well as
DNA. The importance of the overall peptide charge can
be partly explained by the peptide screening the nucleic
acid surface similarly to metal ions. It is a well known fact
that Na
+and Mg
2+ stabilize RNA double strands thermo-
dynamically by reducing the electrostatic stress arising
from the small distances of the RNA backbone phos-
phates, with ions that have a higher charge density being
more effective stabilizers (59). Thus, they accelerate an-
nealing to a certain degree, especially at higher concentra-
tions. Similarly, the multivalent Tat peptide might
accelerate annealing partly because of this screening
effect. However, as the magnitude of acceleration of an-
nealing by Tat(44–61) can not be achieved by a simple
increase of the salt concentration, there must be a different
mechanism that is beyond charge neutralization.
The spatial arrangement of the amino acids in the Tat
peptide is important for its activity
The results discussed in the previous section imply that the
most important factor that confers annealing activity is
the overall charge of the peptide. This could mean that
the peptide acts as an octovalent ion. To assess the
question as to whether a speciﬁc spatial arrangement of
basic amino acids within the peptide is important we
scrambled the peptide in three different ways
(Figure 4A): (i) in the mutant scr1 the eight basic amino
acids are distributed evenly over the peptide; (ii) scr3
contains two stretches of basic residues, as does the WT
peptide, however these are separated by a larger amount
of uncharged amino acids; (iii) scr2 contains only one
basic stretch while the other basic residues are more
distributed.
Interestingly, all three scrambled peptides are less active
than the wild-type peptide in our RNA annealing assay
with scr1 being more active than scr2 and scr3 (Figure 4B).
Thus, the overall charge [which is the same for scr1-3 and
Tat(44–61)] alone is not sufﬁcient to account for the extent
of RNA annealing activity. In every charged molecule
only a limited number of the charged amino acids can
participate in the interaction with the binding partner
due to structural reasons. Quantitatively, this is expressed
by the effective charge Zeff as opposed to the overall
charge (55). Changing Zeff by scrambling the Tat peptide
sequence is likely, even though we expect a peptide of only
18 amino acids length to be extremely ﬂexible which might
result in a similar mean Zeff in the WT and scr1-3. We
hypothesize that, apart from maintaining a certain effect-
ive charge, an annealing competent protein positions its
positively charged residues in a well-deﬁned (but still
unknown) manner in space in order to facilitate rather
deﬁned interactions between amino acids and nucleic
acids.
Binding strength and annealing activity do not correlate
We tested RNA binding of two different peptide mutants
as well as of the wild-type peptide using ﬁlter binding
assays. The RNA of interest was the single-stranded
21R
+, one of the RNA strands used for the FRET-
based annealing assay. We always recorded binding
curves for the mutant peptide of interest in parallel with
the wild-type. We thus obtained relative KD values and
Figure 3. The peptide’s basic amino acids are crucial for the acceleration of annealing. (A) Amino acid sequence of Tat(44–61) with the positively
charged amino acids in bold. (B) Different single amino acid mutants and a double and triple amino acid mutant of Tat(44–61) were tested in our
FRET-based annealing assay with the 21R RNA pair at 30 C (using 300nM peptide). Normalized FRET-values were ﬁtted to the monophasic
second-order reaction equation yielding the kobs for each peptide mutant. The obtained kobs were used to calculate the mutant activities relative to the
WT as follows. In case the kobs(mutant) was higher than the kobs(WT), kobs(mutant) was divided by kobs(WT) and plotted as a positive value. In case
of a decreased mutant kobs relative to the WT kobs, kobs(WT) was divided by kobs(mutant) and plotted as a negative value. This calculation method
was used in order to emphasize speciﬁcally kobs decreases. Notably, the activity of all peptides in which a basic arginine or lysine was exchanged
against alanine was reduced by a factor of 2.5–3 relative to the wild-type peptide. The double and triple mutant ‘K7A R13A’ and ‘K7A R9A R13A’
did not accelerate annealing detectably at the applied conditions. Two peptide mutants (I2T and Y4R) showed a higher annealing activity than
Tat(44–61).
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measured in 16 independent experiments was
1110±434nM. The R13A mutant’s KD is slightly
higher than the wild-type’s KD while the Hill factor
remains unchanged. The K7A R13A mutant’s KD is
double that of the wild-type’s binding constant. The dif-
ferent RNA binding strength of this mutant is also re-
ﬂected in a slightly lower Hill coefﬁcient. The loss of
annealing activity of these two mutants is  70% (R13A)
or complete (K7A R13A) at a peptide concentration of
300nM (see Figure 3B). Thus, the mutants’ loss of
activity is not reﬂected in their binding constants.
We could therefore conﬁrm the missing correlation
between RNA annealing activity and RNA binding as
described by several other groups (14,26,60–62). The
results suggest that, besides RNA/peptide binding,
another process (such as an RNA conformation change)
occurs for which a certain amount of basic amino acids is
necessary. Considering that the removal of one or two
basic amino acids from Tat(44–61) will probably change
the peptide’s conformation, the spatial arrangement of
positive charges might also play a role in this process.
Tat(44–61) does not accelerate annealing through
aggregation
One of the suggested mechanisms for protein accelerated
annealing is the increase of the local nucleic acid
concentration. Several studies have shown that HIV-1 nu-
cleocapsid protein Ncp7 induces the sequence non-speciﬁc
aggregation of nucleic acids which is considered to be a
major element of its chaperone activity (46,63–67). Besides
proteins, different multivalent cations such as spermidine
and spermine compact and aggregate nucleic acids via
electrostatic interactions (68,69) and thus it was suggested
that highly positively charged annealing competent
proteins in general accelerate annealing via this
mechanism.
To address this hypothesis, we tested whether
Tat(44–61) aggregates RNA with a simple centrifugation
assay (46). We found the peptide to be positive in this
assay using single-stranded 21R
+ (Figure 5A) and
double-stranded 21R RNA (data not shown). However,
the addition of BSA to the reaction prevented Tat(44–61)
caused depletion of RNA from the solution almost com-
pletely. Interestingly, BSA had no inﬂuence on the anneal-
ing activity of Tat(44–61) as assayed with the FRET-based
annealing assay (Figure 5B). We therefore assume that the
observed ‘aggregation’ was due to non-speciﬁc binding of
the Tat peptide to test tube walls and that in contrast to
Ncp7 no aggregates were formed. Further experiments
supported this conclusion. MgCl2 and NaCl concentra-
tions that inhibited annealing acceleration by the Tat
peptide (Figure 2) did not affect the outcome of the ag-
gregation assay (Figure 5C and D). In contrast, mono-
and divalent ions have been shown to strongly inﬂuence
Ncp7 induced nucleic acid aggregation (63). We could not
detect a difference in RNA depletion for the three differ-
ent peptide concentrations 100, 200 and 300nM, which
showed different magnitudes of annealing activity as
well. Shorter centrifugation times resulted in less
‘aggregated’ RNA for all three concentrations without
showing any signiﬁcant discrimination between the three
concentrations (Supplementary Figure S9).
We therefore conclude that nucleic acid aggregation
is not the basis for Tat peptide accelerated RNA
annealing.
Tat(44–61) increases the entropy of the annealing
transition state
To learn more about the mechanism of Tat(44–61)-
facilitated annealing we collected annealing rate constants
at different temperatures using gel annealing assays
(Figure 6A–C). From the temperature dependence of the
Figure 4. The spatial arrangement of basic amino acids within the
peptide is important for annealing activity. (A) Primary sequences of
scrambled peptides with the same amino acid composition as the WT
Tat(44–61) peptide. (B) The FRET-based annealing assay using 21R
RNA was carried out at 30 C. The obtained reaction constant kobs of
each peptide mutant was normalized to the WT kobs, yielding the ‘fold
activity relative to the WT’. Interestingly, all scrambled peptides con-
taining the same amount of basic amino acids as Tat(44–61) were less
active than the WT.
Table 1. Binding constants for peptide-RNA binding of two different
peptide mutants relative to the WT peptide
R13A K7A R13A
kobs (mutant): kobs (WT) [ ] 0.43±0.10 0.16±0.04
KD (mutant): KD (WT) [ ] 1.23±0.13 2.27±0.31
h (mutant): h (WT) [ ] 1.07±0.16 0.87±0.10
Relative KD values and Hill factors h were calculated from three inde-
pendent sets of ﬁlter binding experiments. For comparison, the kobs for
mutant peptide accelerated annealing relative to the wild-type reaction
constant is additionally listed.
Nucleic Acids Research, 2011,Vol.39, No. 10 4411rate constant k an Arrhenius plot was drawn (Figure 6D)
and thermodynamic parameters of the transition state of
annealing (Table 2) were calculated as described previ-
ously (29).
The relation between Gibbs free energy, enthalpy and
the entropy term are described by the following equation:
G6¼ ¼ H6¼   T   S6¼: ð7Þ
The Tat peptide increases the activation energy Ea from 40
to 70kJ/mol and concomitantly the transition enthalpy
H
6¼ of annealing by 30kJ/mol which is detrimental to
the reaction. Nevertheless, in the presence of the peptide
the transition free energy G
6¼ is lowered from 40 to
35kJ/mol. This is also reﬂected by the increase of the an-
nealing reaction constant by a factor of 9.5 under these
conditions. Thus, the peptide-induced G
6¼ decrease must
be caused by entropic rather than enthalpic terms.
Consistently, the transition entropy S
6¼ is increased
signiﬁcantly in the presence of Tat(44–61) (Table 2). A
similar thermodynamic effect on RNA annealing has so
far been shown only for the chemical CTAB (29) and
(with a not as pronounced magnitude) for the tumor sup-
pressor protein p53 (17). The interaction of positively
charged peptides with nucleic acids is generally
accompanied by a counterion and water release which
results in a considerable entropy increase (55,70). This
entropy increase is driven solely by the net charge of the
peptide, and not the amino acid arrangement (54). A very
recent study on thermodynamics of binding of the Tat
fragment Tat(46–60) to the TAR RNA conﬁrmed an
entropy increase of the system through RNA–peptide
interaction (71). The calculated entropy increase through
non-speciﬁc binding at 80mM NaCl S
binding was
determined to be 63±4 J/(mol K), which is in the same
range as our calculated entropy increase for the transition
state. We speculate that, also in the case of RNA/RNA
annealing, S
6¼ elevation is mainly driven by counterion
and water release upon peptide binding. The question that
remains unanswered is: What happens to the RNA upon
peptide/RNA interaction that accelerates annealing?
These processes might either support or counteract the
entropic effect of counterion release.
Figure 5. Aggregation and annealing acceleration by the Tat peptide do not correlate. (A) Aggregation assays with 21R
+ ssRNA in the presence of
300nM Tat(44–61),  0.1mg/ml BSA or both proteins were carried out. While BSA did not aggregate the RNA, Tat(44–61) depleted >90% RNA
from the solution. In the presence of BSA, however, Tat(44–61) had only a minor aggregation effect. (B) Interestingly, the same amount of BSA did
not inﬂuence the RNA annealing activity of 300nM of the peptide as determined using the FRET-based annealing assay. (C and D) RNA
aggregation by 300nM Tat(44–61) was assayed under different MgCl2 and NaCl concentrations that had been shown to inhibit the peptide’s
annealing activity to a greater or lesser extent. However, no signiﬁcant difference in measured aggregation was detectable.
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In order to learn more about the structural inﬂuence of
Tat(44–61) on its RNA substrate we recorded 1D
1H
spectra of the 21R+RNA in the absence or presence of
different amounts of Tat peptide and at different tempera-
tures (Figure 7).
The 1D
1H NMR spectra of the 21R
+RNA recorded in
9/1 H2O/D2O-buffer did not show any signals in the
imino-proton region at a temperature range of 0–47 C
(data not shown). Therefore we conclude that under our
experimental conditions the RNA molecule does not
exhibit any secondary-structure elements that involve
base-pair interactions and truly represents an ‘unfolded’
RNA chain. Changing the solvent from H2Ot oD 2O
allows recording of the spectra without the deterring
effect from water suppression. The same signal pattern
of non-exchangeable protons is found, indicating that
changing the solvent has no effect on the conformation
of the RNA.
The NMR spectra of the 21R
+ RNA alone show a
strong temperature-dependent behavior in the range
between 0 and 47 C (Figure 7). At low temperatures,
Figure 6. Tat(44–61) increases the transition state entropy of the annealing reaction. (A) RNA gel annealing assays were conducted in the absence or
presence of protein and at different temperatures. To start the reaction a Cy3-labeled RNA strand was added to the Cy5-labeled complementary
RNA. Aliquots were drawn after certain time points and the reaction was stopped with a 60  excess of non-labeled competitor strand. (B) The
samples were applied directly onto a running native PAGE. Since the Cy5-dyes add ‘size’ to the RNAs the heteroduplex of two labeled strands (**ds)
runs higher than the complex of the Cy3- and the unlabeled strands (*ds). The Cy5- and Cy3-ﬂuorescent signals were scanned and the Cy5-signals
from single and double strands were quantiﬁed. (C) Plotting the ratio of double-stranded RNA to total amount of RNA for each time point of a
reaction yielded annealing curves which were ﬁtted with a monophasic second-order reaction equation with equimolar initial reaction concentration.
With rising temperature the kobs of the annealing reaction in the presence or absence of 300nM Tat(44–61) increased. The rate constants k,
normalized to the RNA concentration, were as follows: Tat(44–61) 5 C 9.0 10
5M
 1s




diamond), 15 C 29.0 10
5M
 1s
 1 (ﬁlled circle), 20 C 40.0 10
5M
 1s
 1 (ﬁlled square); RNA only 10 C 2.4 10
5M
 1s




 1 (open diamond), 30 C 7.3 10
5M
 1s
 1 (open circle), 37 C 10.6 10
5M
 1s
 1 (open square). Means of curves and rate constants k
were calculated from three to four independent experiments. (D) The natural logarithms of the normalized reaction constants k were plotted against
the inverse temperature demonstrating the linear correlation between the two values in the measured temperature range (Arrhenius plot).
Nucleic Acids Research, 2011,Vol.39, No. 10 4413such as 0 C, distinct signals are detectable and show a
reasonable chemical shift dispersion for an RNA void of
any canonical structural elements. As displayed in
Figure 7 (and Supplementary Figure S10), the peaks of
the aromatic protons spread over a spectral region of
 1.3ppm. As the temperature is increased the dispersion
of the signals is lost and the spread of the aromatic
protons is narrowed down to  0.7ppm at 37 C.
Furthermore, the shape of the peaks shows a marked tem-
perature dependence. At temperatures  20–25 C, the
peaks become broad but the line-shape narrows down
again when the temperature is further increased to 37 C
or higher (Supplementary Figure S10). This behavior is
not only observed in the aromatic spectral region, but
for all RNA peaks in the whole spectrum (the line-width
of signals from buffer molecules stay constant within error
over the whole temperature scale). The changes in the
spectrum are reversible and multiple cycles of cooling
and heating over the indicated temperature range always
produces the same spectra. The integrity of the RNA was
conﬁrmed by biochemical methods before and after NMR
measurements.
For a more analytical evaluation of the experimental
spectra, simulated NMR spectra of the 21R
+ RNA were
generated with the NUCHEMICS software. The simula-
tions were based on two structures of the 21R
+RNA: one
representing the single strand in A-form conformation and
a second representing a structurally randomized conform-
ation. Although the exact experimental spectrum could
not be reproduced by the simulation, the chemical shift
dispersion behavior could be reproduced (Supplementary
Figure S11). For the aromatic region, the simulated
spectra show a dispersion of signals over  1.8ppm
based on the A-form conformation, whereas the
randomized conformation leads to a reduction of
chemical shift dispersion down to  0.8ppm and an
overlap of peaks. Generally, the dispersion in RNA
spectra (especially for the aromatic protons in the
nucleo-bases) derives from the stacking behavior of the
RNA chain. Therefore, the absence of helicality in
the RNA reduces the proportion of stacked nucleotides
and the effect on the chemical shifts in the NMR
spectrum is a reduced chemical shift dispersion.
We conclude that at low temperatures a distinct,
probably helical conformation is adopted by the
single-stranded 21R
+ RNA (Figure 8A). When the tem-
perature is raised, this conformation starts to melt.
Around 20–25 C the molecule is no longer best described
by a single static conformation but by an ensemble of
interconverting partially melted ‘helices’. The temperature
increase to 47 C converts the 21R
+ RNA into similar,
unstructured (and most probably unstacked) conform-
ations that give rise to the low dispersion but narrow
line-shape signature of the peaks. This observation is in
accordance with CD-spectroscopic melting experiments
(Supplementary Figure S12). When the CD-temperature
row is analyzed for a two-state unfolding process, the
melting temperature is determined to be Tm=38  C
Figure 7. Tat(44–61) selects a speciﬁc RNA structure.
1H 1D NMR
spectra of 21R
+, a 21nt single stranded RNA, in the absence (black)
or the presence (blue) of two equivalents of Tat(44–61) at different
temperatures (indicated in gray at the right panel of the ﬁgure) were
recorded. The chemical shifts of the aromatic protons did not overlap
with the peptide chemical shifts and serve thus as an indicator for the
peptide’s inﬂuence on the RNA conformation: the only visible peaks of
the peptide in this spectral region are stemming from the aromatic
protons of Y47 and are marked with asterisks. To follow changes in
the spectrum upon addition of peptide gray dotted lines are added
exemplarily, the symbol indicate if peaks are shifting upon addition
of the peptide (less than and greater than symbol) or show no
change (struck through circle).
Table 2. Thermodynamic data at 20 C derived from the Arrhenius plot in Figure6
K (M
 1s




RNA only 4.2 10
5 40±1 40±1 38±1  8±6
Tat(44–61) 300nM 4.0 10
6 70±6 35±1 68±6 112±26





4414 Nucleic Acids Research, 2011,Vol.39, No. 10meaning that at this particular temperature the RNA is in
an equilibrium of 50% unfolded and folded
conformations.
The addition of peptide to the 21R
+changed the RNA
spectra in a temperature dependent way (Figure 7). A
control spectrum of peptide alone demonstrated that
RNA aromatic hydrogen shifts did not overlap with
peptide peaks (Supplementary Figure S13). Thus, the
chemical shift changes upon addition of peptide could
be attributed directly to structural changes within the
RNA, assuming that shift changes in the peptide do not
lead to an overlap in the NMR spectra of the complex.
The addition of peptide Tat(44–61) to the RNA induces
chemical shift changes in the RNA and leads to a broad-
ening of the signals at low (0 C) and high (37 C) tempera-
tures. At these temperatures, the interaction of the RNA
with Tat(44–61) leads to an equilibrium between the
selected conformation and the ground-state conformation
on a timescale turning the peaks in the spectrum broad. At
intermediate temperatures (20 C) (when the signals are
already broad and the chemical shift dispersion is
limited), the spectrum gets more disperse and more
distinct signals and are visible upon addition of peptide.
This is due to the selection of a certain conformation from
the pool of slowly interconverting RNA conformations
(Figure 8).
This conformation selection might be achieved by true
selective binding of already formed RNA conformations
which relocates the equilibrium between different RNA
structures. Another possible reason for the population
change is the modulation of RNA structure upon
peptide binding. Indeed, it has been shown by other
groups that arginine/lysine oligopeptides are able to
change DNA conformations by tilting the bases or
altering the winding angle (70). Regarded on a molecular
level, a lot of encounters between RNA molecules turn out
to be fruitless due to unfavorable RNA conformations
and/or orientations. Switching the RNA molecules to a
favorable conformation and/or orientation would thus
increase the probability of procession from an encounter
to the transition state of duplex formation. At the level of
the RNA molecule ensemble, this activity would have the
propensity to accelerate the overall annealing reaction.
Thus, we suggest that Tat(44–61) shifts the RNA structure
into an annealing-competent form which might be a partly
helical and partly melted conformation as indicated by our
data.
CONCLUSIONS
HIV-1 Tat as well as its fragment Tat(44–61) have potent
nucleic acid annealing activity but do not catalyze strand
displacement and are thus nucleic acid annealers. The
activity of the model peptide Tat(44–61) is based on
ionic interactions between peptide and the RNA
backbone. Therefore, positively charged amino acids
play a dominant role in annealing acceleration while
other amino acids are not important. Both the net
charge of the peptide, as well as an exact arrangement of
basic amino acids within the peptide, determine the mag-
nitude of the annealing activity. Thermodynamically,
Tat(44–61) increases the entropy of the annealing
Figure 8. Schematic representation of peptide-induced RNA structural changes. (A) RNA only, (B) RNA in the presence of Tat(44–61) with its N-
terminus in blue and its C-terminus in red. At low temperature, the interaction of the peptide with the RNA induces changes in the conformational
equilibrium in a way that not only a single helical conformation is present but the helical-conformation is locally disrupted or partially melted. At
intermediate temperatures (close to the ‘melting point’) the RNA is anyhow in a conformational equilibrium between helical and partially melted
conformations. The addition of peptide to this pool of conformers results in a partial stabilization of the partially melted RNA conformations, which
are probably the ones where RNA duplex formation initiates. At high temperatures, Tat(44–61) will stabilize not the completely randomized
unfolded form of the RNA, but intermediates that are prone to interaction with a complementary strand of RNA.
Nucleic Acids Research, 2011,Vol.39, No. 10 4415transition state, thereby decreasing the Gibbs free energy.
According to previous studies, the peptide-conferred
entropy increase is caused by a counterion release upon
peptide binding (55,70). The actual acceleration of anneal-
ing, however, is probably mainly caused by a conversion
of the RNA into an annealing prone conformation. This
RNA conformational change in the presence of peptide
must be detrimental to the reaction’s entropy but its con-
tribution is apparently too small to compensate the
counterion release effect. These ﬁndings also explain the
equal importance of both the peptide’s overall charge and
the basic amino acid distribution: while the peptide net
charge dictates RNA/peptide binding and entropy
increase (54), the basic amino acid distribution probably
mediates the RNA conformational change. We found no
evidence for the contribution of the proposed annealing
mechanism (A) (active increase of the local RNA concen-
tration, see ‘Introduction’ section) to the annealing
activity of the Tat peptide. The potential annealing mech-
anism (B) (stabilization of the annealing transition state
by shielding the negative RNA backbone charges) can be
excluded for Tat(44–61) since it would demand a decrease
of the activation energy Ea. Considering the promiscuous
annealing acceleration of RNAs with different sequences,
it seems obvious that Tat(44–61) does not form strong
complexes with its substrates. Thus, binding constants
might not be of signiﬁcance when discussing RNA anneal-
ers and chaperones. In fact, the interaction of Tat(44–61)
and RNA are most probably of a very transient nature
which we believe to be a key element to annealing accel-
eration (72). Although CTAB-, Ncp7- and p53-facilitated
annealing apparently underlie different mechanisms, we
think that our ﬁndings might apply to other facilitators
of annealing that are rich in basic amino acids, such as
Escherichia coli StpA, ribonucleoprotein hnRNP A1 and
guideRNA binding protein gBP21. In each unique case
other amino acids (like hydrogen bond-forming ones)
might contribute to the activity.
SUPPLEMENTARY DATA
Supplementary Data are available at NAR Online.
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